← Back to Search

Vitamin D Formulation

Regular Vitamin D3 1000IU for Vitamin D

N/A
Waitlist Available
Research Sponsored by Factors Group of Nutritional Companies Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 0 (before treatment), at day 5, 10, 15 (during treatment), at day 30 (end of treatment), at day 45 and 60 (after treatment).
Awards & highlights

Study Summary

This trial is testing two different concentrations of vitamin D to see which is more effective. They are also testing a new microencapsulated LipoMicel Vitamin D formulation to see if it is more effective than the regular vitamin D formulation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 0 (before treatment), at day 5, 10, 15 (during treatment), at day 30 (end of treatment), at day 45 and 60 (after treatment).
This trial's timeline: 3 weeks for screening, Varies for treatment, and at day 0 (before treatment), at day 5, 10, 15 (during treatment), at day 30 (end of treatment), at day 45 and 60 (after treatment). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Weight Changes
Evaluation of Vitamin D serum level: change of 25-Hydroxyvitamin D
Secondary outcome measures
Safety blood work evaluation - change of C Reactive Protein (CRP)
Safety blood work evaluation - change of alanine aminotransferase (ALT)
Safety blood work evaluation - change of alkaline phosphatase
+8 more

Trial Design

4Treatment groups
Active Control
Group I: Regular Vitamin D3 1000IUActive Control1 Intervention
The first group receives regular Vitamin D3 1000IU
Group II: Microencapsulated Vitamin D3 1000IUActive Control1 Intervention
The second group receives microencapsulated Vitamin D3 1000IU
Group III: Regular Vitamin D3 2500IUActive Control1 Intervention
The third group receives regular Vitamin D3 2500IU
Group IV: Microencapsulated Vitamin D3 2500IUActive Control1 Intervention
The fourth group receives microencapsulated Vitamin D3 2500IU

Find a Location

Who is running the clinical trial?

Factors Group of Nutritional Companies Inc.Lead Sponsor
7 Previous Clinical Trials
194 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we still looking for more participants for this research?

"That is correct, the online information from clinicaltrials.gov says that this study is currently enrolling patients. This trial was first posted on January 1st, 2022 and has since been edited August 2nd of the same year. They are looking for 50 individuals total between 1 site."

Answered by AI

Is this research project enrolling adults who are still under the age of majority?

"This study's eligibility requirements state that patients must be between 21-65 years old. If a potential patient does not meet this age criterion, there are two other trials they could possibly enroll in."

Answered by AI

What are the main goals of this clinical trial?

"According to the study sponsor, Factors Group of Nutritional Companies Inc., the primary outcome metric for this trial is change in serum vitamin d levels over time. This will be measured at baseline (before treatment), and then again at days 5, 10, 15 (during treatment), day 30 (end of treatment), as well as 45 and 60 post-treatment. Additionally, this clinical trial will also measure secondary outcomes including changes in creatinine and aminotransferase levels before and after the intervention."

Answered by AI

How can I sign up for the chance to participate in this experiment?

"This study is looking for 50 individuals who are currently taking vitamin d supplements and meet the following criteria: age between 21 and 65 years; avoid consumption of any additional food supplements containing vitamin D; avoid use of tanning beds or other artificial UVB sources. Participants must complete an online questionnaire on their medical history, weight, height, lifestyle (smoking, exercising etc.) and dietary habits relating to food rich in vitamin D, including other dietary supplementations."

Answered by AI

How many patients are eligible for this clinical trial?

"Yes, the information on clinicaltrials.gov points out that this clinical trial is presently searching for patients. The study was first posted on 1/1/2022 and was most recently edited on 8/2/2022. The trial is enrolling 50 patients across 1 sites"

Answered by AI
~11 spots leftby Apr 2025